Global Oncology Drugs Market to Cross USD 763 Billion by 2035: Report
The growth of the oncology drugs market is driven by rising cancer prevalence, advancements in targeted therapies and immunotherapy, and the expansion of precision medicine.
E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
The growth of the oncology drugs market is driven by rising cancer prevalence, advancements in targeted therapies and immunotherapy, and the expansion of precision medicine.
Johnson & Johnson said the CHMP opinion is an important step towards positioning the off-the-shelf immunotherapy combination of teclistamab and daratumumab as a potential new standard of care earlier in the multiple myeloma treatment pathway.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.

